A groundbreaking vaccine developed by Japanese researchers is potentially capable of preventing or modifying the course of Alzheimer's disease. This novel vaccine targets senescence-associated glycoprotein (SAGP), expressed in inflamed brain cells linked to Alzheimer's.
A groundbreaking vaccine developed by Japanese researchers is potentially capable of preventing or modifying the course of Alzheimer's disease. This novel vaccine targets senescence-associated glycoprotein (SAGP), expressed in inflamed brain cells linked to Alzheimer's.
Share this Article
Recommended